DDReg pharma

Quailty Driven by Passion

All Category

Home » All Category » Page 19

Kenya’s Systematic Approach to Pharmacovigilance

Pharmacovigilance (PV) and drug safety surveillance activities rely on a robust PV system. This is important to effectively identify, evaluate, and address any adverse events (AEs) that are associated with medicinal products. Indeed, a proficient PV system facilitates data gathering that is critical for making informed decisions across various health systems. Regulatory agencies are reliant […]

Kenya’s Systematic Approach to Pharmacovigilance Read More »

MHRA’s AI-Airlock for Safe Development of Medical Technologies

The use of artificial intelligence (AI) in the Pharmaceutical and Health Care industries has paved the way for more innovative opportunities to help enhance patient outcomes. This is with respect to the diagnosis, treatment, and overall personalized patient care. However, as these technologies evolve, so do the challenges especially when it comes to testing these

MHRA’s AI-Airlock for Safe Development of Medical Technologies Read More »

Predetermined Change Control Plans for Machine Learning-Enabled Medical Devices

As more artificial intelligence (AI) and machine learning (ML) technologies become increasingly available, the uniqueness of medical devices also evolve. Though AI/ML-driven devices provide support for diagnosing and treating more complex conditions, their unique features highlight the need for a more harmonized approach towards device regulation for patient safety. Regulators across the globe are gradually

Predetermined Change Control Plans for Machine Learning-Enabled Medical Devices Read More »

ISoP: The Need for Patient Engagement in Pharmacovigilance

Pharmacovigilance is paramount for the well-being of patients exposed to pharmaceutical products. To ensure the effectiveness of pharmacovigilance systems professionals from various scientific disciplines contribute in diverse manner. Several organizations collaborate to ensure best global pharmacovigilance practices for patient safety. Among these key organizations is the International Society of Pharmacovigilance (ISoP) that is dedicated to patient

ISoP: The Need for Patient Engagement in Pharmacovigilance Read More »

AMDF: Ensuring the Safety of Donated Medical Devices

In times of emergencies like war, disease outbreak, natural disasters etc that lead to a rise in casualties, humanitarian support such as donations may be required. These donations can range from basic items like clothing to more technical complex items such as medical devices. While donations can be crucial during emergencies, they also bring challenges

AMDF: Ensuring the Safety of Donated Medical Devices Read More »

DDReg attends the OTC Health and Wellness Conference 2023

The OTC Health and Wellness Conference was held on the 3rd of November 2023. Organized by the Organization of Pharmaceutical Producers of India (OPPI) at the PHD House in New Delhi, it aimed to address the need for self-care and support consumers with evidence-based information regarding the safety of over the counter (OTC) medicines. The

DDReg attends the OTC Health and Wellness Conference 2023 Read More »

Japan PMDA: The Role of In-Country Clinical Caretakers

Japan has a robust regulatory framework for pharmaceuticals and medical devices, which includes specific requirements for In-Country Clinical Caretakers (ICCC). Foreign manufacturers that wish to penetrate the Japanese market must appoint an ICC, who resides in Japan, to sponsor the clinical trials on their behalf. Thus, they play a crucial part in ensuring that foreign

Japan PMDA: The Role of In-Country Clinical Caretakers Read More »

Regulatory Framework for Cosmetics in South Korea

The cosmetics sector in South Korea has witnessed impressive expansion and gained global acclaim. The Ministry of Food and Drug Safety (MFDS) has implemented a strong regulatory system, primarily overseen by the Cosmetics Act, to guarantee the safety and quality of cosmetic items. The Cosmetics Regulatory Framework, in conjunction with additional regulations, plays a crucial

Regulatory Framework for Cosmetics in South Korea Read More »

Pharmacovigilance in Herbal and Alternative Medicine

At the turn of the millennium, guidelines for post-marketing safety reporting of herbal medicines were introduced by the World Health Organization (WHO) in the period between 1999 and 2001. The fact that more than 158 million people in the United States alone spent over 17.6 billion dollars on herbal medicines in the year 2000 is

Pharmacovigilance in Herbal and Alternative Medicine Read More »